Skip to content
Homepage
Author:
SYSTIMMUNE.INC
Posted Date:
May 21, 2026
New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
SYSTIMMUNE.INC
May 21, 2026
SystImmune, Inc. to Present New iza-bren (izalontamab brengitecan) Data in Extensive Stage Small Cell Lung Cancer at ELCC 2026
SYSTIMMUNE.INC
May 3, 2026
